ArticleBrain & spine2026
Decoding calvarial lesions: Contemporary neurosurgical management integrating radiological and histopathological features.
Article in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Calvarial lesions range from benign tumors to malignant processes and pose diagnostic and surgical challenges due to their rarity and heterogeneous imaging features. Research question: Which clinical and radiological features distinguish benign from malignant calvarial lesions, and how do they influence neurosurgical management and outcomes? Material and methods: We performed a retrospective study of patients undergoing neurosurgical treatment for calvarial lesions between 2013 and 2025. Clinical, radiological, surgical, and histopathological data were analyzed. Functional outcomes (KPS, GOS, mRS), comorbidity measures (ASA classification, BMI), and frailty (modified 5-Item Frailty Index) were assessed. Imaging evaluation included CT-based bone morphology and MRI. Results: A total of 174 patients were included; 66.1% had benign and 33.9% malignant lesions. Malignant lesions were associated with older age, higher frailty, and comorbidity burden. The most common diagnoses were meningioma and metastases. Multiple osteolytic lesions on CT were associated with malignancy and remained the strongest independent predictor (OR: 5.34; 95% CI: 2.35-12.14). Gross total resection was achieved in 82.8% of cases (83.5% in benign vs. 81.3% in malignant lesions, p = 0.8), with significant postoperative functional improvement (KPS), particularly in benign lesions (p < 0.0001). Overall, recurrence occurred in 3.4% of patients and was more frequent in malignant than benign lesions (6.8% vs. 1.7%, p = 0.2). Discussion and conclusion: Multiple osteolytic lesions represent a key radiological marker of malignancy and support preoperative risk stratification. Distinguishing benign from malignant lesions is essential, as it informs surgical strategy and the extent of resection, enabling individualized patient management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.